CWHP_Logo_Horizontal.jpg
The Center for Workforce Health and Performance and National Association of Worksite Health Centers Release Report to Help Employers and Insurers Manage Musculoskeletal Conditions
April 22, 2021 08:03 ET | The Center for Workforce Health and Performance
OAKLAND, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Disability leaves for musculoskeletal conditions such as back pain and arthritis are estimated to cost insurers and employers about $6.3 billion...
AposHealth logo.png
HealthCare Partners Expands Relationship with AposHealth® to Bring an Innovative, Non-Invasive Treatment for Knee Osteoarthritis to Members Through a New Delivery Model
February 02, 2021 09:00 ET | AposHealth®
NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- HealthCare Partners (HCP) today announced an expansion of its partnership with AposHealth® to bring an innovative, non-invasive treatment for knee...
Herniated Disc: How Chiropractors Can Help with Spinal Decompression to Avoid Surgery
October 27, 2020 13:59 ET | Dr. Phillips Chiropractic, Nutrition and Wellness
SAN ANTONIO, Texas, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Back pain, inflammation, and weakness caused by a herniated disc can prevent you from being an active participant in your own life. Spinal...
Back To School Back Problems: Heavy Backpacks and Books
October 05, 2020 17:54 ET | Dr. Phillips Chiropractic, Nutrition and Wellness
SAN ANTONIO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Back pain is a common problem for Americans, including children and teenagers. Many parents do not realize how their child packs and carries their...
BioDelivery Sciences logo
BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
July 09, 2019 08:00 ET | BioDelivery Sciences International, Inc.
Regional Commercial Plans Improved Access for More Than 6 Million Lives During 2Q More Than 90% of Commercial Lives Now Have Access to BELBUCA in the U.S. RALEIGH, N.C., July 09, 2019 (GLOBE...
BioDelivery Sciences logo
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
May 29, 2019 16:10 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., May 29, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences logo
BioDelivery Sciences Strengthens Financial Position with Debt Refinancing
May 28, 2019 16:10 ET | BioDelivery Sciences International, Inc.
New Agreement is Cash Flow Accretive, Lowers Cost of Capital and Extends Debt Maturity Reduces Annual Interest Costs by Approximately $1.5 million Increases Flexibility to Continue Growth Trajectory...
BioDelivery Sciences logo
BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCA® Full-Year Expectations
May 06, 2019 16:05 ET | BioDelivery Sciences International, Inc.
BELBUCA® Net Sales Increased by 134% versus Prior Year to All-time High of $18.7 MillionSymproic® Acquisition and Commercial Integration Successfully CompletedCompany Raises Full-Year BELBUCA Net...
BioDelivery Sciences logo
BioDelivery Sciences to Report First Quarter 2019 Financial Results
April 25, 2019 16:30 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., April 25, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences logo
BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock
April 10, 2019 16:07 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., April 10, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) (“BDSI” or the “Company”) today announced that it is commencing an underwritten public...